Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients
Authors:
- Olga V. MalyshevaOMOlga V. Malysheva
- Natalia Yu. ShvedNSNatalia Yu. Shved
- Tatyana E. IvashchenkoTITatyana E. Ivashchenko
- Iskender Yu. SultanovISIskender Yu. Sultanov
- Olga A. EfimovaOEOlga A. Efimova
- Maria I. YarmolinskayaMYMaria I. Yarmolinskaya
- Vitaly F. BezhenarVBVitaly F. Bezhenar
- Vladislav S. BaranovVBVladislav S. Baranov
- 1 November 2016
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 35 (6) , 509-515
Abstract
Uterine leiomyomas (ULs) are common benign tumors affecting women of different ethnicities. A large proportion of UL has mutations in MED12. Multiple and solitary ULs usually manifest with different severities, suggesting that their origin and growth pattern may be driven by different molecular mechanisms. Here, we compared the frequency and the spectrum of MED12 exon 2 mutations between multiple (n=82) and solitary (n=40) ULs from Russian patients. Overall, we detected MED12 exon 2 mutations in 51.6% (63/122) of ULs. The frequency of MED12 exon 2 mutations was almost two-fold higher in samples from the multiple UL patients than in those from the solitary UL patients – 61% (50/82) versus 32.5% (13/40). The increased MED12 exon 2 mutation frequency in the multiple ULs was not accompanied by significant alterations in the spectrum of mutation categories, which included missense mutations, deletions, splicing defects, and multiple (double/triple) mutations. Each mutation category had a unique mutation set, comprising both frequent and rarely encountered mutations, which did and did not overlap between the studied groups, respectively. We conclude that in contrast to the solitary ULs, the multiple ULs predominantly originate through MED12-associated mechanisms. The nature of these mechanisms seems to be similar in solitary and multiple ULs, as they contain similar mutations. In multiple UL patients, they are likely to be nonsporadic, indicating the existence of specific factors predisposing to multiple UL development. These data suggest that to clearly understand UL pathogenesis, solitary and multiple tumors should probably be analyzed as separate sets.Keywords
This publication has 33 references indexed in Scilit:
- Number and size of uterine fibroids and obstetric outcomesThe Journal of Maternal-Fetal & Neonatal Medicine, 2014
- Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyomaGenes, Chromosomes and Cancer, 2012
- Clinical presentation of fibroidsBest Practice & Research Clinical Obstetrics & Gynaecology, 2008
- Incidence, aetiology and epidemiology of uterine fibroidsBest Practice & Research Clinical Obstetrics & Gynaecology, 2008
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyomaCancer Genetics and Cytogenetics, 2005
- Biallelic Inactivation of Fumarate Hydratase (FH) Occurs in Nonsyndromic Uterine Leiomyomas but Is Rare in Other TumorsThe American Journal of Pathology, 2004
- High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidenceAmerican Journal of Obstetrics and Gynecology, 2003
- PCOLCE deletion and expression analyses in uterine leiomyomataCancer Genetics and Cytogenetics, 2002
- ORC5L, a New Member of the Human Origin Recognition Complex, Is Deleted in Uterine Leiomyomas and Malignant Myeloid DiseasesJournal of Biological Chemistry, 1998
- Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and RaceObstetrics & Gynecology, 1997